Aryl sulfonic acids and derivatives as fsh antagonists
This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently,...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.10.2000
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently, hydrogen, OR , -S(O)mR , -NHR , -N(R )2, or -CH2SO2CH3; R and R are each, independently, hydrogen, -NO2, -NH2, -SO2R , or -CH2R ; R is hydrogen, C1 to C6 alkyl, C3 to C6 alkenyl, -CH2CH2Z, -CH2COR , -CH2CH=CHCOR , (e), (f) or (g); Y1 and Y are each, independently, N, or CH; Y and Y are each independently, O, S, or NR ; R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; Z is -OR8, -OCH2CH2OR , -N(R )2, or (h); R8 is hydrogen or C1 to C3 alkyl; R is C1 to C6 alkyl, C3 to C6 alkenyl, OH, NHR , N(R )2, CH2COR , -CH2CH=CHCOR , or (i); R is C1 to C3 alkyl, C3 to C4 alkenyl, phenyl, -CH2CH2OCH3, or -(j); R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; R is hydrogen, or C1 to C3 alkyl; R is hydrogen, or C1 to C3 alkyl; W is a bond, CH2, CH2CH2, O, S(O)q, NCHO, NCOCH3, or NR ; m is 0 - 2; n is 0 - 2; q is 0 - 2, with the proviso that R and R are not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents. |
---|---|
AbstractList | This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or -CH2S(O)nCH2-; R is OH, NH2, C1 to C6 alkoxy, C1 to C3 perfluoroalkoxy; Ar is (a) or (b); Ar' is (c) or (d); R and R are each, independently, hydrogen, OR , -S(O)mR , -NHR , -N(R )2, or -CH2SO2CH3; R and R are each, independently, hydrogen, -NO2, -NH2, -SO2R , or -CH2R ; R is hydrogen, C1 to C6 alkyl, C3 to C6 alkenyl, -CH2CH2Z, -CH2COR , -CH2CH=CHCOR , (e), (f) or (g); Y1 and Y are each, independently, N, or CH; Y and Y are each independently, O, S, or NR ; R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; Z is -OR8, -OCH2CH2OR , -N(R )2, or (h); R8 is hydrogen or C1 to C3 alkyl; R is C1 to C6 alkyl, C3 to C6 alkenyl, OH, NHR , N(R )2, CH2COR , -CH2CH=CHCOR , or (i); R is C1 to C3 alkyl, C3 to C4 alkenyl, phenyl, -CH2CH2OCH3, or -(j); R is -OR , -NHR , -N(R )2, or -NHCH2CH2OR ; R is hydrogen, or C1 to C3 alkyl; R is hydrogen, or C1 to C3 alkyl; W is a bond, CH2, CH2CH2, O, S(O)q, NCHO, NCOCH3, or NR ; m is 0 - 2; n is 0 - 2; q is 0 - 2, with the proviso that R and R are not both hydrogen; or pharmaceutically acceptable salt thereof, which are useful as contraceptive agents. |
Author | DANIEL MICHAEL GREEN JOHN FRANCIS ROGERS JAY EDWARD WROBEL JAMES WINFIELD JETTER WENLING KAO |
Author_xml | – fullname: JAMES WINFIELD JETTER – fullname: JOHN FRANCIS ROGERS – fullname: WENLING KAO – fullname: JAY EDWARD WROBEL – fullname: DANIEL MICHAEL GREEN |
BookMark | eNrjYmDJy89L5WQwcyyqzFEoLs1Jy8_LTFZITM5MKVZIzEtRSEktyixLLMksSwXyixXSijOAwiWJ6UBlxSXFPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3jHUxMDE1MLAwNGYsAoA5qYugw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | AU4045800A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU4045800A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:56:33 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU4045800A3 |
Notes | Application Number: AU20000040458 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001016&DB=EPODOC&CC=AU&NR=4045800A |
ParticipantIDs | epo_espacenet_AU4045800A |
PublicationCentury | 2000 |
PublicationDate | 20001016 |
PublicationDateYYYYMMDD | 2000-10-16 |
PublicationDate_xml | – month: 10 year: 2000 text: 20001016 day: 16 |
PublicationDecade | 2000 |
PublicationYear | 2000 |
RelatedCompanies | AMERICAN HOME PRODUCTS CORPORATION |
RelatedCompanies_xml | – name: AMERICAN HOME PRODUCTS CORPORATION |
Score | 2.5227134 |
Snippet | This invention provides compounds of formula (I) having the structure wherein Q is hydrogen or -SO2R ; X is a bond, O, S(O)n, -CH=CH-, -CH2CH2-, -CC-, or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Aryl sulfonic acids and derivatives as fsh antagonists |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20001016&DB=EPODOC&locale=&CC=AU&NR=4045800A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LSwMxEB5qFfWmVanvHGRvi7Hd52GR7T4oQh9IK72VpNmlhbItzVbx3zsJXfXSWx4wTJKZZJKZ-QLwxH3KfFx3081bjmm5jJuel7VMlCUno0x4vv7urdd3umPrbWJPajCvcmE0TuiXBkdEjZqhvpd6v17_PWLFOrZSPvMFNq1e01EQG9XtWCOmGXEnSIaDeBAZUYQ3SaP_HljKIUhpeACHaES7SheSj47KSVn_P1DSMzgaIq2iPIdaVjTgJKr-XWvAcW_n7sbiTvPkBTjh5ntJ5HaZKyxbwmYLIQkrBBEoQp8avRvrkuRyjs3K1aQgceUlPKbJKOqayMD0d6zTcFxx2r6CerEqsiaQmcNZnouc21RYXNgctxnKvReLobllC_samvuo3OzvuoVTnVeuwjOcO6iXm212jydsyR_05PwAau2AnA |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf7MHsbXHCNsbDYmAfQYVBzDC8Le26BRIyCB0a_3uvDVNfeOtHcrm2d-21d_crwAPt6qSL6651spalGR1CNdtOWxrKkpXqhNld-d3bKLQGU-N1Zs4qMC9zYSRO6JcER0SNSlDfC7lfr_8esTwZW8kf6QKbVs9B5HhqeTuWiGmq13f8ydgbu6rr4k1SDd8dQzgEdb13AIdoYHeELvgffZGTsv5_oASncDRBWnlxBpU0r0PNLf9dq8PxaOfuxuJO8_g5WL3N91Lh22UmsGwVkiwYV0jOFIYi9CnRu7HOlYzPsVm4mgQkLr-AZuBH7kBDBuLfsca9aclp-xKq-SpPG6AkFiVZxjJq6sygzKS4zejUfjIImlsmM6-gsY_K9f6uJtQG0WgYD1_Ctxs4kTnmIlTDuoVqsdmmd3jaFvReTtQPnnKDjw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Aryl+sulfonic+acids+and+derivatives+as+fsh+antagonists&rft.inventor=JAMES+WINFIELD+JETTER&rft.inventor=JOHN+FRANCIS+ROGERS&rft.inventor=WENLING+KAO&rft.inventor=JAY+EDWARD+WROBEL&rft.inventor=DANIEL+MICHAEL+GREEN&rft.date=2000-10-16&rft.externalDBID=A&rft.externalDocID=AU4045800A |